WHO’s position on HPV vaccines: Part 1, real world questions


June 16, 1:52 PMVaccines ExaminerNorma Erickson

Countries around the globe look to the World Health Organization for guidance when designing programs impacting public health. At least that is the way things are supposed to be. When it comes to HPV vaccination programs, government health officials, NGO’s and vaccine manufacturers all appear to be ignoring WHO’s official HPV vaccines position paper.

Prior to publication of their official position paper, the World Health Organization asked experts on vaccines and immunizations from within and outside their organization around the world to review and endorse the information included in their official stance. Their goal was to provide information and guidance to all involved in the vaccination process, from the manufacturer to the recipient of any HPV vaccines.

Everyone except the recipients of the vaccines, their families, and civilian health advocates seem to be ignoring the information provided by these experts.

Consider the following statements from WHO’ s position paper (in bold) and the questions raised by those statements:

  1. Most HPV infections are transient and benign: Some studies estimate that up to 80% of people will be exposed to HPV during their lifetime. Up to 90% of these infections clear up on their own with no intervention in two years, according to the American Cancer Society. If most HPV infections do not cause cancer and clear up on their own, why is a vaccine necessary?



Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.